PILOT PROJECT 2: ESTROGEN RECEPTOR SPLICE VARIANT & MENOPAUSAL DEPRESSION

试点项目 2:雌激素受体剪接变体

基本信息

  • 批准号:
    7959834
  • 负责人:
  • 金额:
    $ 3.48万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-07-01 至 2010-06-30
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Several rigorous, standardized psychiatric diagnoses studies conclude that vulnerability to a major depressive disorder (MDD) is increased at the time of the menopause transition. About 75% of perimenopausal women reported mood and sleep disorders and these disorders are likely to recur at menopause in women with bipolar illness (Parry, 2008). Estrogen replacement therapy resulted in significant (more than 80%) anti-depressive effects in pre-, perimenopausal women but has no effects in late post-menopausal women. The mechanism of the functional, structural or mechanistic alterations of estrogen response during menopausal transition remains unclear and elucidating the nature of the loss of response to exogenous estrogen in late post-menopausal women forms the objective of this proposal. We and other groups have recently identified several estrogen receptor (ER) splice variants including the dominant negative ERbeta variant, ERbeta2 in rat hippocampus. Further more, our pilot data demonstrated an increase of ERbeta2 expression in hippocampus of rats ovariectomized (OVX) more than 21 days, but not in those OVX for 5 days or non OVX. Coincident with increase of ERbeta2 expression in hippocampus of 21 days OVX rats is the loss of estrogen-induced neurogenesis which currently believe is a neural basis for antidepressants. Therefore, we hypothesize that menopausal related ERbeta2 expression may serve as a biomarker and perhaps also as a functional switch for the menopause-related loss of estrogen antidepressive effects. Three specific AIMs are designed to validate our hypothesis. 1) CHARACTERIZE THE OVARIECTOMY-INDUCED ER¿2 ISOFORM EXPRESSION IN BRAINS OF RATS AND RHESUS MONKEYS. 2) DETERMINE THE IMPACT OF ER¿2 ON E2-REGULATED BRAIN ANTI-DEPRESSIVE EFFECTS IN OVX RAT AND NON-HUMAN PRIMATE BRAIN. 3) DETERMINE THE IMPACT OF ERB2 ON E2-REGULATED BEHAVIORAL ANTI-DEPRESSIVE EFFECTS IN OVX RATS.
这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金, 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 一些严格的、标准化的精神病学诊断研究得出结论,易患抑郁症 在更年期过渡时,精神障碍(MDD)的发病率会增加。约75%的围绝经期妇女 已报告的情绪和睡眠障碍以及这些障碍很可能在患有双相情感障碍的女性更年期时复发 疾病(Parry,2008)。雌激素替代疗法显著(80%以上)抗抑郁 对绝经前、围绝经期妇女有影响,但对绝经后晚期妇女没有影响。其作用机制是 绝经过渡期间雌激素反应的功能性、结构性或机械性变化 绝经后晚期妇女对外源性雌激素反应丧失的本质不清楚和阐明 形成了这项提案的目标。 我们和其他小组最近发现了几种雌激素受体(ER)剪接变异体,包括 大鼠海马区显性负性ERβ变异体ERbeta2。此外,我们的试点数据表明, 卵巢切除21d以上大鼠海马区ERbeta2表达增加,但未见明显变化 去卵巢5天或不去卵巢的患者。与21日龄大鼠海马区ERbeta2表达增加一致 OVX大鼠失去雌激素诱导的神经发生,目前认为这是神经基础 抗抑郁药。因此,我们假设与绝经相关的ERbeta2的表达可能作为一种 生物标志物,也可能是绝经后雌激素丢失的功能开关 抗抑郁作用。我们设计了三个具体的目标来验证我们的假设。1)描述 卵巢切除诱导大鼠和恒河猴脑内ER?2亚型的表达2)确定 雌激素受体2对雌激素调节的去卵巢大鼠和非人灵长类动物脑内抗抑郁作用的影响 大脑。3)观察ERB2对去卵巢大鼠雌激素调节的行为抗抑郁作用的影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Junming Wang其他文献

Junming Wang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Junming Wang', 18)}}的其他基金

Ethanol induced brain injury is decreased by inhibiting TIEG2 mediated cell death
通过抑制 TIEG2 介导的细胞死亡来减少乙醇引起的脑损伤
  • 批准号:
    8702049
  • 财政年份:
    2011
  • 资助金额:
    $ 3.48万
  • 项目类别:
SMALL GRANT 2: ESTROGEN RECEPTOR SPLICE VARIANT & MENOPAUSAL DEPRESSION
小额资助 2:雌激素受体剪接变体
  • 批准号:
    8360510
  • 财政年份:
    2011
  • 资助金额:
    $ 3.48万
  • 项目类别:
PILOT PROJECT 2: ESTROGEN RECEPTOR SPLICE VARIANT & MENOPAUSAL DEPRESSION
试点项目 2:雌激素受体剪接变体
  • 批准号:
    8167937
  • 财政年份:
    2010
  • 资助金额:
    $ 3.48万
  • 项目类别:

相似国自然基金

Behavioral Insights on Cooperation in Social Dilemmas
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    万元
  • 项目类别:
    外国优秀青年学者研究基金项目

相似海外基金

CAREER: Early-life social environments drive behavioral and neural mechanisms of development
职业:早期社会环境驱动行为和神经机制的发展
  • 批准号:
    2341006
  • 财政年份:
    2024
  • 资助金额:
    $ 3.48万
  • 项目类别:
    Continuing Grant
NSF PRFB FY 2023: Assessing morphological, behavioral, and genetic impacts of methylmercury on spiders.
NSF PRFB 2023 财年:评估甲基汞对蜘蛛的形态、行为和遗传影响。
  • 批准号:
    2305949
  • 财政年份:
    2024
  • 资助金额:
    $ 3.48万
  • 项目类别:
    Fellowship Award
A mobile health solution in combination with behavioral change approach to improve vaccination coverage and timeliness in Bangladesh: A cluster randomized control trial
移动健康解决方案与行为改变方法相结合,以提高孟加拉国的疫苗接种覆盖率和及时性:集群随机对照试验
  • 批准号:
    24K20168
  • 财政年份:
    2024
  • 资助金额:
    $ 3.48万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The role of nigrostriatal and striatal cell subtype signaling in behavioral impairments related to schizophrenia
黑质纹状体和纹状体细胞亚型信号传导在精神分裂症相关行为障碍中的作用
  • 批准号:
    10751224
  • 财政年份:
    2024
  • 资助金额:
    $ 3.48万
  • 项目类别:
CAREER:HCC: Using Virtual Reality Gaming to Develop a Predictive Simulation of Human-Building Interactions: Behavioral and Emotional Modeling for Public Space Design
职业:HCC:使用虚拟现实游戏开发人类建筑交互的预测模拟:公共空间设计的行为和情感建模
  • 批准号:
    2339999
  • 财政年份:
    2024
  • 资助金额:
    $ 3.48万
  • 项目类别:
    Continuing Grant
ICE-TI: A Decolonized Approach to an AAS in Social and Behavioral Sciences
ICE-TI:社会和行为科学中 AAS 的非殖民化方法
  • 批准号:
    2326751
  • 财政年份:
    2024
  • 资助金额:
    $ 3.48万
  • 项目类别:
    Continuing Grant
Differentiating innate and conditioned fear in behavioral level using pupillometry and neural level using brain-wide traveling wave
使用瞳孔测量法区分行为水平上的先天性恐惧和条件性恐惧,并使用全脑行波区分神经水平上的先天性恐惧和条件性恐惧
  • 批准号:
    23K28389
  • 财政年份:
    2024
  • 资助金额:
    $ 3.48万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Bilingualism as a cognitive reserve factor: the behavioral and neural underpinnings of cognitive control in bilingual patients with aphasia
双语作为认知储备因素:双语失语症患者认知控制的行为和神经基础
  • 批准号:
    10824767
  • 财政年份:
    2024
  • 资助金额:
    $ 3.48万
  • 项目类别:
Collaborative Research: Behavioral Science and the Making of the Right-Reasoning Public Health Citizenry
合作研究:行为科学与正确推理的公共卫生公民的培养
  • 批准号:
    2341512
  • 财政年份:
    2024
  • 资助金额:
    $ 3.48万
  • 项目类别:
    Continuing Grant
Collaborative Research: Behavioral Science and the Making of the Right-Reasoning Public Health Citizenry
合作研究:行为科学与正确推理的公共卫生公民的培养
  • 批准号:
    2341513
  • 财政年份:
    2024
  • 资助金额:
    $ 3.48万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了